Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 6 for:    Aptose
Previous Study | Return to List | Next Study

A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02267863
Recruitment Status : Recruiting
First Posted : October 20, 2014
Last Update Posted : June 4, 2020
Sponsor:
Information provided by (Responsible Party):
Aptose Biosciences Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2022
Estimated Study Completion Date : May 2022